As of 2025-05-19, the Intrinsic Value of Touchstone International Medical Science Co Ltd (688013.SS) is 13.17 CNY. This 688013.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 22.60 CNY, the upside of Touchstone International Medical Science Co Ltd is -41.70%.
The range of the Intrinsic Value is 9.31 - 23.89 CNY
Based on its market price of 22.60 CNY and our intrinsic valuation, Touchstone International Medical Science Co Ltd (688013.SS) is overvalued by 41.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9.31 - 23.89 | 13.17 | -41.7% |
| DCF (Growth 10y) | 11.33 - 27.75 | 15.71 | -30.5% |
| DCF (EBITDA 5y) | 15.17 - 22.57 | 17.76 | -21.4% |
| DCF (EBITDA 10y) | 16.26 - 25.77 | 19.69 | -12.9% |
| Fair Value | 13.67 - 13.67 | 13.67 | -39.51% |
| P/E | 10.66 - 20.10 | 14.92 | -34.0% |
| EV/EBITDA | 6.21 - 12.60 | 8.50 | -62.4% |
| EPV | 2.72 - 3.61 | 3.17 | -86.0% |
| DDM - Stable | 6.33 - 22.67 | 14.50 | -35.8% |
| DDM - Multi | 9.40 - 26.43 | 13.90 | -38.5% |
| Market Cap (mil) | 1,834.22 |
| Beta | 1.32 |
| Outstanding shares (mil) | 81.16 |
| Enterprise Value (mil) | 1,801.19 |
| Market risk premium | 6.13% |
| Cost of Equity | 9.27% |
| Cost of Debt | 5.00% |
| WACC | 9.26% |